[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609139":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":36,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":55,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Simon SOUDET, Dr","CONTACT","33+3 22 08 80 51","soudet.simon@chu-amiens.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"CHU Amiens","RECRUITING","Amiens","80480","France",{"type":22,"coordinates":23},"Point",[24,25],2.3,49.9,{"lat":25,"lon":24},[28,31,34],{"name":29,"role":11,"phone":30,"phoneExt":7,"email":13},"SOUDET Simon, MD","03 22 88 72 89",{"name":32,"role":33,"phone":7,"phoneExt":7,"email":7},"Laurent Bertoletti, MD","PRINCIPAL_INVESTIGATOR",{"name":35,"role":33,"phone":7,"phoneExt":7,"email":7},"Lina Khider, MD",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100609139",false,"NCT07210671","Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous","SUPERCAT","Inclusion Criteria:\n\n* Patient over 18\n* Patient affiliated to a social security scheme\n* Patient who understands French\n* Patient with superficial venous thrombosis of the lower and upper limbs confirmed by a Doppler ultrasound less than one month old.\n* Patient with active cancer:\n* Cancer treatment within the last 6 months,\n* Detectable tumor disease, cancer treatment within the last 6 months, ongoing hormone therapy for cancer, palliative cancer.\n* The patient has received potentially non-curative cancer treatment (notably palliative chemotherapy).\n* Progression shows that the cancer treatment was not curative (due to recurrence or progression under treatment) (particularly in the case of recurrence after surgery)\n\nExclusion Criteria:\n\n* Patients under legal protection\n* Patients with concomitant pulmonary embolism\n* Patient with proximal or distal deep vein thrombosis\n* Patient treated with anticoagulant therapy for another indication\n* Patient with a contraindication to anticoagulation: Thrombocytopenia less than 30,000 elements\u002Fmm3, active bleeding or history of severe bleeding.\n* Patient opposed to participation in research","ALL","18 Years",{"count":47,"type":48},1576,"ESTIMATED","OBSERVATIONAL","Superficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials for DVT. There is therefore no high-level evidence-based treatment recommendation for these patients. Recent data suggest that the course of cancer-associated DVT is similar to that of cancer-associated deep vein thrombosis (DVT). However, there are currently few prospective data on the evolution of cancer-associated DVT in relation to the treatment used. Due to the absence of clear recommendations of treatment in case of SVT associated with cancer the investigators will perform a prospective observational study to evaluate the efficacy of different regiment of anticoagulant treatment ordered in clinical practice.",[52,53,54],"Superficial Vein Thrombosis","Cancer","Venous Thrombosis",[56,57,58],"Superficial vein thrombosis","cancer","venous thrombosis","2026-04-09",{"date":61,"type":62},"2026-04-14","ACTUAL",{"date":64,"type":62},"2025-11-10",{"date":66,"type":48},"2028-11",{"name":5,"class":6},1]